Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry.
Jazmati D, Hero B, Thole-Kliesch TM, Merta J, Deubzer HE, Bäumer C, Heinzelmann F, Schleithoff SS, Koerber F, Eggert A, Schwarz R, Simon T, Timmermann B. Jazmati D, et al. Among authors: merta j. Curr Oncol. 2022 Oct 30;29(11):8222-8234. doi: 10.3390/curroncol29110649. Curr Oncol. 2022. PMID: 36354709 Free PMC article.
Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry.
Jazmati D, Butzer S, Hero B, Ahmad Khalil D, Merta J, Bäumer C, Plum G, Fuchs J, Koerber F, Steinmeier T, Peters S, Doyen J, Thole T, Schmidt M, Blase C, Tippelt S, Eggert A, Schwarz R, Simon T, Timmermann B. Jazmati D, et al. Among authors: merta j. Front Oncol. 2021 Jan 20;10:617506. doi: 10.3389/fonc.2020.617506. eCollection 2020. Front Oncol. 2021. PMID: 33552991 Free PMC article.
Proton Beam Therapy for Pediatric Tumors of the Central Nervous System-Experiences of Clinical Outcome and Feasibility from the KiProReg Study.
Peters S, Frisch S, Stock A, Merta J, Bäumer C, Blase C, Schuermann E, Tippelt S, Bison B, Frühwald M, Rutkowski S, Fleischhack G, Timmermann B. Peters S, et al. Among authors: merta j. Cancers (Basel). 2022 Nov 28;14(23):5863. doi: 10.3390/cancers14235863. Cancers (Basel). 2022. PMID: 36497345 Free PMC article.
Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study.
Peters S, Merta J, Schmidt L, Jazmati D, Kramer PH, Blase C, Tippelt S, Fleischhack G, Stock A, Bison B, Rutkowski S, Pietsch T, Kortmann RD, Timmermann B. Peters S, et al. Among authors: merta j. Neuro Oncol. 2022 Jul 1;24(7):1193-1202. doi: 10.1093/neuonc/noab301. Neuro Oncol. 2022. PMID: 34964901 Free PMC article.
Overcoming inter-observer planning variability in target volume contouring and dose planning for high-risk neuroblastoma - a European multicenter effort of the SIOPEN radiotherapy committee.
Jazmati D, Brualla L, Littooij AS, Webber B, Dieckmann K, Janssens GO, Simon T, Gaze MN, Merta J, Serrano A, Dietzsch S, Kramer PH, Wulff J, Boterberg T, Timmermann B. Jazmati D, et al. Among authors: merta j. Radiother Oncol. 2023 Apr;181:109464. doi: 10.1016/j.radonc.2023.109464. Epub 2023 Jan 11. Radiother Oncol. 2023. PMID: 36640946 Clinical Trial.